search
Back to results

Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS) (BABS)

Primary Purpose

Evaluation of Expected Bone Loss After Bariatric Surgery, Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D Supplementation

Status
Completed
Phase
Phase 2
Locations
Austria
Study Type
Interventional
Intervention
Calciferol, calcium carbonate
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Evaluation of Expected Bone Loss After Bariatric Surgery

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • body mass index >35
  • female and male patients
  • age 18 - 65 years
  • eligible for laparoscopic gastric bypass surgery according to the Austrian national guidelines

Exclusion Criteria:

  • any history of malignancy except basalioma
  • any prior antiresorptive treatment
  • any prior calcium or vitamin D supplementation
  • any secondary disease affecting bone metabolism

Sites / Locations

  • Medical University Vienna

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Calcium/Vitamin D

No Calcium/Vitamin D

Arm Description

All subjects will receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery as follows: daily: 500 mg oral calcium (calcium carbonate) weekly: 16.000 IU oral vitamin D3 (calciferol)

All subjects will not receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery.

Outcomes

Primary Outcome Measures

Evaluation of bone mineral density changes in obese patients after laparoscopic bariatric surgery
Dual energy X-ray absorptiometry (DXA) measurements of bone mineral density at lumbar spine, hip, calcaneus and total body will be performed at baseline and every six months for a period of 24 months. Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation

Secondary Outcome Measures

Evaluation of changes of serum bone turnover markers in obese patients after laparoscopic bariatric surgery
Fasting serum markers of bone formation and bone resorption will be evaluated: Calcium, 25-OH-vitamin D3, intact parathyroid hormone, beta-crosslaps, type-1-procollagen, bone specific alkaline phosphatase, osteocalcin, sclerostin, osteoprotegerin, cathepsin-K, fibroblast factor 23, lipoprotein A, dickkopf 1 Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation

Full Information

First Posted
November 23, 2012
Last Updated
August 22, 2014
Sponsor
Medical University of Vienna
search

1. Study Identification

Unique Protocol Identification Number
NCT01739855
Brief Title
Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS)
Acronym
BABS
Official Title
Phase 2 Study of Patients Undergoing Bariatric Surgery (Laparoscopic Gastric Bypass) and Evaluation of Bone Metabolism With/Without Vitamin D/Calcium Supplementation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
August 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Bariatric surgery leads to rapid weight loss in female and male patients. Less data are available about its impact on bone metabolism. The aim of this study is the investigation of changes in bone mineral density,bone histomorphometric changes, serum bone turnover markers and changes in body fat and muscle composition in patients after laparoscopic gastric bypass surgery.
Detailed Description
Obese female and male adult patients eligible for laparoscopic gastric bypass surgery according to the national Austrian guidelines will be included in this study upon request and after patient approval. Baseline data collection and quarterly follow up visits are planned to investigate the changes in bone mineral density and body composition measured by dual energy X-ray absorptiometry as well as the evaluation of serum bone turnover markers of bone formation and resorption. After surgery subjects will be randomized into two groups: Daily oral calcium (500mg) and weekly vitamin D3 supplementation (16.000 IU calciferol)or no supplementation of calcium and calciferol. A sub-study (approximately 15% of study population) with transiliac bone biopsies will also be performed to investigate histomorphometric and histologic changes in bone (biopsy baseline and after 24 months). The planned duration of the study is 24 months for each subject. Serum bone turnover markers will be collected every 3 months, dual energy X-ray absorptiometry measurements will be performed every 6 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Evaluation of Expected Bone Loss After Bariatric Surgery, Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D Supplementation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Calcium/Vitamin D
Arm Type
Active Comparator
Arm Description
All subjects will receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery as follows: daily: 500 mg oral calcium (calcium carbonate) weekly: 16.000 IU oral vitamin D3 (calciferol)
Arm Title
No Calcium/Vitamin D
Arm Type
No Intervention
Arm Description
All subjects will not receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery.
Intervention Type
Drug
Intervention Name(s)
Calciferol, calcium carbonate
Primary Outcome Measure Information:
Title
Evaluation of bone mineral density changes in obese patients after laparoscopic bariatric surgery
Description
Dual energy X-ray absorptiometry (DXA) measurements of bone mineral density at lumbar spine, hip, calcaneus and total body will be performed at baseline and every six months for a period of 24 months. Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation
Time Frame
Evaluation every 6 months for 24 months
Secondary Outcome Measure Information:
Title
Evaluation of changes of serum bone turnover markers in obese patients after laparoscopic bariatric surgery
Description
Fasting serum markers of bone formation and bone resorption will be evaluated: Calcium, 25-OH-vitamin D3, intact parathyroid hormone, beta-crosslaps, type-1-procollagen, bone specific alkaline phosphatase, osteocalcin, sclerostin, osteoprotegerin, cathepsin-K, fibroblast factor 23, lipoprotein A, dickkopf 1 Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation
Time Frame
Evaluation every 3 months for 24 months
Other Pre-specified Outcome Measures:
Title
Evaluation of histomorphometric and histologic changes in obese patients after laparoscopic bariatric surgery
Description
Transiliac bone biopsies will be performed in a approximately 15% of patients at baseline and after 24 months. The following parameters will be measured: bone volume (BV/TV), bone surface (BS/BV), osteoblast surface (OS/BS), trabecular number (TbN), trabecular thickness (TbTh, trabecular separation (Tb.sp), mineralized surface (MS/BS), mineral apposition rate (MAR) Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU colecalciferol) supplementation
Time Frame
baseline and after 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: body mass index >35 female and male patients age 18 - 65 years eligible for laparoscopic gastric bypass surgery according to the Austrian national guidelines Exclusion Criteria: any history of malignancy except basalioma any prior antiresorptive treatment any prior calcium or vitamin D supplementation any secondary disease affecting bone metabolism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Muschitz, M.D.
Organizational Affiliation
Medical University Vienna - Austria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University Vienna
City
Vienna
ZIP/Postal Code
1060
Country
Austria

12. IPD Sharing Statement

Citations:
PubMed Identifier
26350034
Citation
Muschitz C, Kocijan R, Haschka J, Zendeli A, Pirker T, Geiger C, Muller A, Tschinder B, Kocijan A, Marterer C, Nia A, Muschitz GK, Resch H, Pietschmann P. The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study. J Bone Miner Res. 2016 Mar;31(3):672-82. doi: 10.1002/jbmr.2707. Epub 2015 Sep 30.
Results Reference
derived
Links:
URL
http://www.vinforce.at
Description
Homepage of local research team (in German)

Learn more about this trial

Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS)

We'll reach out to this number within 24 hrs